These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33353724)

  • 21. Preclinical Evaluation of
    Honer M; Gobbi L; Knust H; Kuwabara H; Muri D; Koerner M; Valentine H; Dannals RF; Wong DF; Borroni E
    J Nucl Med; 2018 Apr; 59(4):675-681. PubMed ID: 28970331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the binding of tau imaging ligands to melanin-containing cells: putative off-target-binding site.
    Tago T; Toyohara J; Harada R; Furumoto S; Okamura N; Kudo Y; Takahashi-Fujigasaki J; Murayama S; Ishii K
    Ann Nucl Med; 2019 Jun; 33(6):375-382. PubMed ID: 30796626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-Activity Relationship of 2-Arylquinolines as PET Imaging Tracers for Tau Pathology in Alzheimer Disease.
    Tago T; Furumoto S; Okamura N; Harada R; Adachi H; Ishikawa Y; Yanai K; Iwata R; Kudo Y
    J Nucl Med; 2016 Apr; 57(4):608-14. PubMed ID: 26697966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissecting the Binding Profile of PET Tracers to Corticobasal Degeneration Tau Fibrils.
    Zhou Y; Li J; Nordberg A; Ågren H
    ACS Chem Neurosci; 2021 Sep; 12(18):3487-3496. PubMed ID: 34464084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of [
    Tezuka T; Takahata K; Seki M; Tabuchi H; Momota Y; Shiraiwa M; Suzuki N; Morimoto A; Nakahara T; Iwabuchi Y; Miura E; Yamamoto Y; Sano Y; Funaki K; Yamagata B; Ueda R; Yoshizaki T; Mashima K; Shibata M; Oyama M; Okada K; Kubota M; Okita H; Takao M; Jinzaki M; Nakahara J; Mimura M; Ito D
    Brain Commun; 2021; 3(4):fcab190. PubMed ID: 34632382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The development and validation of tau PET tracers: current status and future directions.
    Okamura N; Harada R; Ishiki A; Kikuchi A; Nakamura T; Kudo Y
    Clin Transl Imaging; 2018; 6(4):305-316. PubMed ID: 30148121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A quantitative in vivo imaging platform for tracking pathological tau depositions and resultant neuronal death in a mouse model.
    Kimura T; Ono M; Seki C; Sampei K; Shimojo M; Kawamura K; Zhang MR; Sahara N; Takado Y; Higuchi M
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4298-4311. PubMed ID: 35798978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tau PET imaging: present and future directions.
    Saint-Aubert L; Lemoine L; Chiotis K; Leuzy A; Rodriguez-Vieitez E; Nordberg A
    Mol Neurodegener; 2017 Feb; 12(1):19. PubMed ID: 28219440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Tau Radiotracers in Chronic Traumatic Encephalopathy.
    Varlow C; Vasdev N
    J Nucl Med; 2023 Mar; 64(3):460-465. PubMed ID: 36109185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and evaluation of 2-pyrrolopyridinylquinoline derivatives as selective tau PET tracers for the diagnosis of Alzheimer's disease.
    Lerdsirisuk P; Harada R; Hayakawa Y; Shimizu Y; Ishikawa Y; Iwata R; Kudo Y; Okamura N; Furumoto S
    Nucl Med Biol; 2021 Feb; 93():11-18. PubMed ID: 33221641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of Tau Load Using [
    Golla SSV; Timmers T; Ossenkoppele R; Groot C; Verfaillie S; Scheltens P; van der Flier WM; Schwarte L; Mintun MA; Devous M; Schuit RC; Windhorst AD; Lammertsma AA; Boellaard R; van Berckel BNM; Yaqub M
    Mol Imaging Biol; 2017 Dec; 19(6):963-971. PubMed ID: 28374171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer's disease cases.
    Malarte ML; Nordberg A; Lemoine L
    Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1093-1102. PubMed ID: 32970217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tau PET Imaging.
    Higuchi M
    Adv Exp Med Biol; 2019; 1184():217-230. PubMed ID: 32096041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of tau positron emission tomography tracer [
    Sander K; Lashley T; Gami P; Gendron T; Lythgoe MF; Rohrer JD; Schott JM; Revesz T; Fox NC; Årstad E
    Alzheimers Dement; 2016 Nov; 12(11):1116-1124. PubMed ID: 26892233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An autoradiographic evaluation of AV-1451 Tau PET in dementia.
    Lowe VJ; Curran G; Fang P; Liesinger AM; Josephs KA; Parisi JE; Kantarci K; Boeve BF; Pandey MK; Bruinsma T; Knopman DS; Jones DT; Petrucelli L; Cook CN; Graff-Radford NR; Dickson DW; Petersen RC; Jack CR; Murray ME
    Acta Neuropathol Commun; 2016 Jun; 4(1):58. PubMed ID: 27296779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tau PET imaging in Alzheimer's disease.
    Okamura N; Harada R; Furumoto S; Arai H; Yanai K; Kudo Y
    Curr Neurol Neurosci Rep; 2014 Nov; 14(11):500. PubMed ID: 25239654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discriminatory ability of next-generation tau PET tracers for Alzheimer's disease.
    Yap SY; Frias B; Wren MC; Schöll M; Fox NC; Årstad E; Lashley T; Sander K
    Brain; 2021 Sep; 144(8):2284-2290. PubMed ID: 33742656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies.
    Ono M; Sahara N; Kumata K; Ji B; Ni R; Koga S; Dickson DW; Trojanowski JQ; Lee VM; Yoshida M; Hozumi I; Yoshiyama Y; van Swieten JC; Nordberg A; Suhara T; Zhang MR; Higuchi M
    Brain; 2017 Mar; 140(3):764-780. PubMed ID: 28087578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo positron emission tomographic imaging of glial responses to amyloid-beta and tau pathologies in mouse models of Alzheimer's disease and related disorders.
    Maeda J; Zhang MR; Okauchi T; Ji B; Ono M; Hattori S; Kumata K; Iwata N; Saido TC; Trojanowski JQ; Lee VM; Staufenbiel M; Tomiyama T; Mori H; Fukumura T; Suhara T; Higuchi M
    J Neurosci; 2011 Mar; 31(12):4720-30. PubMed ID: 21430171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls.
    Maruyama M; Shimada H; Suhara T; Shinotoh H; Ji B; Maeda J; Zhang MR; Trojanowski JQ; Lee VM; Ono M; Masamoto K; Takano H; Sahara N; Iwata N; Okamura N; Furumoto S; Kudo Y; Chang Q; Saido TC; Takashima A; Lewis J; Jang MK; Aoki I; Ito H; Higuchi M
    Neuron; 2013 Sep; 79(6):1094-108. PubMed ID: 24050400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.